GSK has announced that the US FDA has accepted for priority review a supplemental Biologics License Application for Jemperli ...
A July 2026 Leerink Partners report named Carterra a core enabling technology in the growing Lab‑in‑the‑Loop market. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results